Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signalingNiranjan Awasthi, Roderich E. Schwarz|Laboratory Investigation|2008Cited by 65
Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancerNiranjan Awasthi, Roderich E. Schwarz|Oncotarget|2017Cited by 35
Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP IINiranjan Awasthi, Roderich E. Schwarz|Journal of Experimental & Clinical Cancer Research|2013Cited by 30
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancerNiranjan Awasthi, Roderich E. Schwarz|BMC Cancer|2011Cited by 26
Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer modelsMeghan Grojean, Niranjan Awasthi|Journal of Cellular and Molecular Medicine|2021Cited by 24